Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-24

Clinical Trial Update: G-Pen™ for Hypoglycemia Rescue in T1D Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the G-Pen glucagon rescue device for treating hypoglycemia in people with type 1 diabetes; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • G-Pen (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia | Phase 2 | Status: COMPLETED | Results posted: 2017-04-24